Burke Porter Group acquires NACS, a Minnesota-based contract manufacturer of medical devices

Client	BPG is designer, developer and manufacturer of highly sophisticated manufacturing equipment used by its customers in mission critical applications including end of line quality assurance, diagnostics, and complex research applications. BPG serves significant global multinational customers from over 40 locations in 14 countries in Transportation and Test, Advance Manufacturing and Life Sciences. BPG’s continuing strategic objectives are to build upon its presence life science diagnostics and other highly differentiated medical manufacturing technologies. NACS was an addition to that strategy for BPG.
Seller	NACS was a privately held business with significant new business with a major medical device company supportive of the sale to BPG to support European expansion of manufacturing capabilities.
Transaction	Buyer acquired 100% of the Company. Certain Sellers remained as key managers of the Company post close.
Consideration	Cash at close.
Valuation	Undisclosed

Situation Review
- Kinsella Group was engaged to assist BPG in building its life science division through acquisition.
Transaction Process
- Kinsella Group identified a large number of germane prospects and developed relationships leading to an offer for NACS further leading to a closed transaction.
Outcomes
- BPG has aggressively expand manufacturing resources to respond to increased product demand from key customers.
- Key managers were retained to continue impressive growth in revenues and profits.

Case Study